Quantitative susceptibility mapping (QSM): Decoding MRI data for a tissue magnetic biomarker

Magnetic Resonance in Medicine

Volumn 73, Issue 1, 2015, Pages 82-101

  Wang, Yi ^a,b,c   Liu, Tian ^d  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b Cornell University   (United States)

^c Kyung Hee University   (South Korea)

^d Medimagemetric LLC   (United States)

Author keywords

Bayesian; Calcification; Contrast agent; Dipole field; Dipole kernel; Ferritin; Gradient echo; Hemoglobin; Hemorrhage; Iron; Metabolism; Morphology enabled dipole inversion; Myelin; Oxygen consumption; QSM; Quantification; Quantitative susceptibility mapping

Indexed keywords

BAYESIAN NETWORKS; BIOMINERALIZATION; BONE; CALCIFICATION (BIOCHEMISTRY); CHEMICAL SHIFT; HEMOGLOBIN; IRON; MAGNETIC SUSCEPTIBILITY; MAPPING; METABOLISM; MOLECULES; SIGNAL SYSTEMS; TISSUE;

BAYESIAN; CONTRAST AGENT; DIPOLE FIELDS; DIPOLE KERNEL; FERRITIN; GRADIENT ECHO; HEMORRHAGE; MYELIN; OXYGEN CONSUMPTION; QUANTIFICATION; SUSCEPTIBILITY MAPPING;

MAGNETISM;

CONTRAST MEDIUM; IRON; OXYGEN; BIOLOGICAL MARKER;

ALGORITHM; ARTICLE; BLOOD; CALCIFICATION; DEGRADATION KINETICS; DEMYELINATION; IMAGE ANALYSIS; MAGNETIC FIELD; MAGNETISM; NUCLEAR MAGNETIC RESONANCE IMAGING; OXYGEN CONSUMPTION; PATHOPHYSIOLOGY; PHYSICAL CAPACITY; POLARIZATION; QUANTITATIVE SUSCEPTIBILITY MAPPING; RADIOLOGICAL PARAMETERS; CHEMISTRY; COMPUTER ASSISTED DIAGNOSIS; FEMALE; HUMAN; IMAGE ENHANCEMENT; MALE; METABOLISM; MOLECULAR IMAGING; PROCEDURES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

ALGORITHMS; BIOMARKERS; FEMALE; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MOLECULAR IMAGING; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84919781997     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.25358     Document Type: Article

References (238)

1. Wang Y. Principles of Magnetic Resonance Imaging: physics concepts, pulse sequences & biomedical applications. 2012. Available at: www.createspace.com/4001776. Accessed December 1, 2013.
2. de Crespigny AJ, Roberts TP, Kucharcyzk J, Moseley ME. Improved sensitivity to magnetic susceptibility contrast. Magn Reson Med 1993;30:135-137.
3. Haacke EM, Xu Y, Cheng YC, Reichenbach JR. Susceptibility weighted imaging (SWI). Magn Reson Med 2004;52:612-618.
4. Haacke EM, Reichenbach J. Susceptibility weighted imaging in MRI: basic concepts and clinical applications. Hoboken, NJ: Wiley-Blackwell; 2011.
5. Jackson JD. Classical electrodynamics, 3rd ed. Hoboken, NJ: John Wiley and Son; 1999. p. 184-188.
6. Young IR, Khenia S, Thomas DG, Davis CH, Gadian DG, Cox IJ, Ross BD, Bydder GM. Clinical magnetic susceptibility mapping of the brain. J Comput Assist Tomogr 1987;11:2-6.
7. Li L, Leigh JS. Quantifying arbitrary magnetic susceptibility distributions with MR. Magn Reson Med 2004;51:1077-1082.
8. Mahdi K, Wlodarczyk W, Lange T, Scholz R, Jordan A, Wust P. Quantitative mapping of magnetic fluid distributions by means of MR susceptometry. In Proceedings of the 9th Annual Meeting of ISMRM, Glasgow, Scotland, UK, 2001. p. 797.
9. Haacke EM, Cheng NY, House MJ, Liu Q, Neelavalli J, Ogg RJ, Khan A, Ayaz M, Kirsch W, Obenaus A. Imaging iron stores in the brain using magnetic resonance imaging. Magn Reson Imaging 2005;23:1-25.
10. Shmueli K, de Zwart JA, van Gelderen P, Li TQ, Dodd SJ, Duyn JH. Magnetic susceptibility mapping of brain tissue in vivo using MRI phase data. Magn Reson Med 2009;62:1510-1522.
11. de Rochefort L, Brown R, Prince MR, Wang Y. Quantitative MR susceptibility mapping using piece-wise constant regularized inversion of the magnetic field. Magn Reson Med 2008;60:1003-1009.
12. Kressler B, de Rochefort L, Spincemaille P, Liu T, Wang Y. Estimation of sparse magnetic susceptibility distributions from MRI using non-linear regularization. In Proceedings of the 16th Annual Meeting of ISMRM, Toronto, Canada, 2008. p. 1514.
13. Yeo DT, Fessler JA, Kim B. Motion robust magnetic susceptibility and field inhomogeneity estimation using regularized image restoration techniques for fMRI. Med Image Comput Comput Assist Interv 2008;11:991-998.
14. Liu T, Spincemaille P, de Rochefort L, Kressler B, Wang Y. Calculation of susceptibility through multiple orientation sampling (COSMOS): a method for conditioning the inverse problem from measured magnetic field map to susceptibility source image in MRI. Magn Reson Med 2009;61:196-204.
15. Wang Y, de Rochefort L, Liu T, Kressler B. Magnetic source MRI: a new quantitative imaging of magnetic biomarkers. Conf Proc IEEE Eng Med Biol Soc 2009;2009:53-56.
16. Morgan J, Irarrazaval P. Efficient solving for arbitrary susceptibility distributions using residual difference fields. In Proceedings of the 15th Annual ISMRM Meeting-ESMRMB, Berlin, Germany, 2007. p. 35.
17. de Rochefort L, Liu T, Kressler B, Liu J, Spincemaille P, Lebon V, Wu J, Wang Y. Quantitative susceptibility map reconstruction from MR phase data using bayesian regularization: validation and application to brain imaging. Magn Reson Med 2010;63:194-206.
18. Kressler B, De Rochefort L, Spincemaille P, Liu T, Wang Y. Estimation of sparse magnetic susceptibility distributions from MRI using non-linear regularization. In Proceedings of the 16th Annual Meeting of ISMRM, Toronto, Canada, 2008. p. 1514.
19. Liu J, Liu T, de Rochefort L, et al. Morphology enabled dipole inversion for quantitative susceptibility mapping using structural consistency between the magnitude image and the susceptibility map. Neuroimage 2012;59:2560-2568.
20. Liu T, Wisnieff C, Lou M, Chen W, Spincemaille P, Wang Y. Nonlinear formulation of the magnetic field to source relationship for robust quantitative susceptibility mapping. Magn Reson Med 2013;69:467-476.
21. Kressler B, de Rochefort L, Liu T, Spincemaille P, Jiang Q, Wang Y. Nonlinear regularization for per voxel estimation of magnetic susceptibility distributions from MRI field maps. IEEE Trans Med Imaging 2010;29:273-281.
22. Wharton S, Schafer A, Bowtell R. Susceptibility mapping in the human brain using threshold-based k-space division. Magn Reson Med 2010;63:1292-1304.
23. Li W, Wu B, Liu C. Quantitative susceptibility mapping of human brain reflects spatial variation in tissue composition. Neuroimage 2011;55:1645-1656.
24. Chen Z, Calhoun V. Computed inverse resonance imaging for magnetic susceptibility map reconstruction. J Comput Assist Tomogr 2012;36:265-274.
25. Schweser F, Sommer K, Deistung A, Reichenbach JR. Quantitative susceptibility mapping for investigating subtle susceptibility variations in the human brain. Neuroimage 2012;62:2083-2100.
26. Schweser F, Deistung A, Sommer K, Reichenbach JR. Toward online reconstruction of quantitative susceptibility maps: superfast dipole inversion. Magn Reson Med 2013;69:1582-1594.
27. Wu B, Li W, Guidon A, Liu C. Whole brain susceptibility mapping using compressed sensing. Magn Reson Med 2012;67:137-147.
28. Bilgic B, Fan AP, Polimeni JR, Cauley SF, Bianciardi M, Adalsteinsson E, Wald LL, Setsompop K. Fast quantitative susceptibility mapping with L1-regularization and automatic parameter selection. Magn Reson Med 2014;72:1444-1459.
29. Bilgic B, Chatnuntawech I, Fan AP, Setsompop K, Cauley SF, Wald LL, Adalsteinsson E. Fast image reconstruction with L2-regularization. J Magn Reson Imaging 2014;40:181-191.
30. Tang J, Liu S, Neelavalli J, Cheng YC, Buch S, Haacke EM. Improving susceptibility mapping using a threshold-based K-space/image domain iterative reconstruction approach. Magn Reson Med 2013;69:1396-1407.
31. de Rochefort L, Nguyen T, Brown R, Spincemaille P, Choi G, Weinsaft J, Prince MR, Wang Y. In vivo quantification of contrast agent concentration using the induced magnetic field for timeresolved arterial input function measurement with MRI. Med Phys 2008;35:5328-5339.
32. Lamb WE. Internal diamagnetic fields. Phys Rev 1941;60:817-819.
33. Ramsey NF. Magnetic shielding of nuclei in molecules. Phys Rev 1950;78:5.
34. Schindler M, Kutzelnigg W. Theory of magnetic-susceptibilities and NMR chemical-shifts in terms of localized quantities. III. Application to Hydrocarbons and Other Organic-Molecules. J Am Chem Soc 1983;105:1360-1370.
35. Duyn J. MR susceptibility imaging. J Magn Reson 2013;229:198-207.
36. Lauffer RB. Paramagnetic metal complexes as water proton relaxation agents for NMR imaging: theory and design. Chem Rev 1987;87:901-927.
37. Hahn EL. Spin echoes. Phys Rev 1950;80:580-594.
38. Bloembergen N, Morgan LO. Proton relaxation times in paramagetic solutions. effects of electron spin relaxation. J Chem Phys 1961;34:8.
39. Solomon I. Relaxation processes in a system of two spins. Phys Rev 1955;99:559-565.
40. Yablonskiy DA, Haacke EM. Theory of NMR signal behavior in magnetically inhomogeneous tissues: the static dephasing regime. Magn Reson Med 1994;32:749-763.
41. Jensen JH, Chandra R, Ramani A, Lu H, Johnson G, Lee SP, Kaczynski K, Helpern JA. Magnetic field correlation imaging. Magn Reson Med 2006;55:1350-1361.
42. Roemer PB, Edelstein WA, Hayes CE, Souza SP, Mueller OM. The NMR phased array. Magn Reson Med 1990;16:192-225.
43. Pruessmann KP, Weiger M, Scheidegger MB, Boesiger P. SENSE: sensitivity encoding for fast MRI. Magn Reson Med 1999;42:952-962.
44. Parker DL, Du YP, Davis WL. The voxel sensitivity function in Fourier transform imaging: applications to magnetic resonance angiography. Magn Reson Med 1995;33:156-162.
45. Tyler DJ, Robson MD, Henkelman RM, Young IR, Bydder GM. Magnetic resonance imaging with ultrashort TE (UTE) PULSE sequences: technical considerations. J Magn Reson Imaging 2007;25:279-289.
46. Robson MD, Gatehouse PD, Bydder M, Bydder GM. Magnetic resonance: an introduction to ultrashort TE (UTE) imaging. J Comput Assist Tomogr 2003;27:825-846.
47. Weiger M, Pruessmann KP, Hennel F. MRI with zero echo time: hard versus sweep pulse excitation. Magn Reson Med 2011;66:379-389.
48. Xu B, Liu T, Spincemaille P, Prince M, Wang Y. Flow compensated quantitative susceptibility mapping for venous oxygenation imaging. Magn Reson Med 2014;72:438-445.
49. ∗ with multi-echo and multi-shot spirals. Neuroimage 2012;59:297-305.
50. Xu B, Liu T, Spincemaille P, Thimmappa N, Prince MR, Wang Y. Dynamic quantitative susceptibility mapping for contrast agent concentration. In Proceedings of the 21st Annual Meeting of ISMRM, Salt Lake City, Utah, USA, 2013. p. 3847.
51. Lim IA, Li X, Jones CK, Farrell JA, Vikram DS, van Zijl PC. Quantitative magnetic susceptibility mapping without phase unwrapping using WASSR. Neuroimage 2014;86:265-279.
52. Nocedal J, Wright SJ. Numerical optimization. New York: Springer; 2006. pp. xxii, 664.
53. Pei M, Nguyen TD, Thimmappa ND, Salustri C, Dong F, Cooper MA, Li J, Prince MR, Wang Y. Algorithm for fast monoexponential fitting based on auto-regression on linear operations (ARLO) of data. Magn Reson Med 2014. doi: 10.1002/mrm.25137.
54. Bernstein MA, Grgic M, Brosnan TJ, Pelc NJ. Reconstructions of phase contrast, phased array multicoil data. Magn ResonMed 1994;32:330-334.
55. Thunberg P, Karlsson M, Wigstrom L. Comparison of different methods for combining phase-contrast images obtained with multiple coils. Magn Reson Imaging 2005;23:795-799.
56. Lu K, Liu TT, Bydder M. Optimal phase difference reconstruction: comparison of two methods. Magn Reson Imaging 2008;26:142-145.
57. Robinson S, Grabner G, Witoszynskyj S, Trattnig S. Combining phase images from multi-channel RF coils using 3D phase offset maps derived from a dual-echo scan. Magn Reson Med 2011;65:1638-1648.
58. Parker DL, Payne A, Todd N, Hadley JR. Phase reconstruction from multiple coil data using a virtual reference coil. Magn Reson Med 2014;72:563-569.
59. Ghiglia DC, Pritt MD. Two-dimensional phase unwrapping: theory, algorithms, and software. New York: Wiley & Sons; 1998. pp. xiv, 493.
60. Jenkinson M. Fast, automated, N-dimensional phase-unwrapping algorithm. Magn Reson Med 2003;49:193-197.
61. Schofield MA, Zhu Y. Fast phase unwrapping algorithm for interferometric applications. Opt Lett 2003;28:1194-1196.
62. Li W, Avram AV, Wu B, Xiao X, Liu C. Integrated Laplacian-based phase unwrapping and background phase removal for quantitative susceptibility mapping. NMR Biomed 2014;27:219-227.
63. Xu W, Cumming I. A region-growing algorithm for InSAR phase unwrapping. IEEE Trans Geosci Remote Sens 1999;37:11.
64. Witoszynskyj S, Rauscher A, Reichenbach JR, Barth M. Phase unwrapping of MR images using Phi UN-A fast and robust region growing algorithm. Med Image Anal 2009;13:257-268.
65. Cusack R, Papadakis N. New robust 3-D phase unwrapping algorithms: application to magnetic field mapping and undistorting echoplanar images. Neuroimage 2002;16:754-764.
66. Seo JK, Woo EJ, Katscher U, Wang Y. Electro-magnetic tissue properties MRI. Ammari H, editor. London, UK: Imperial College Press; 2014.
67. Langham MC, Magland JF, Floyd TF, Wehrli FW. Retrospective correction for induced magnetic field inhomogeneity in measurements of large-vessel hemoglobin oxygen saturation by MR susceptometry. Magn Reson Med 2009;61:626-633.
68. Wang Y, Yu Y, Li D, Bae KT, Brown JJ, Lin W, Haacke EM. Artery and vein separation using susceptibility-dependent phase in contrastenhanced MRA. J Magn Reson Imaging 2000;12:661-670.
69. Liu T, Khalidov I, de Rochefort L, Spincemaille P, Liu J, Tsiouris AJ, Wang Y. A novel background field removal method for MRI using projection onto dipole fields (PDF). NMR Biomed 2011;24:1129-1136.
70. Schweser F, Deistung A, Lehr BW, Reichenbach JR. Quantitative imaging of intrinsic magnetic tissue properties using MRI signal phase: an approach to in vivo brain iron metabolism? Neuroimage 2011;54:2789-2807.
71. Evans LC. Partial differential equations. Providence, RI: American Mathematical Society; 2010. pp. xxi, 749.
72. Courant R, Hilbert D. Methods of mathematical physics. New York: Interscience Publishers; 1989.
73. Zhou D, Liu T, Spincemaille P, Wang Y. Background field removal by solving the Laplacian boundary value problem. NMR Biomed 2014;27:312-319.
74. Press WH. Numerical recipes: the art of scientific computing. 3rd ed. Cambridge, UK; New York: Cambridge University Press; 2007. pp. 636-643.
75. Li L. Averaging of harmonic physical fields over an annular region enclosing field sources. Am J Phys 2002;70:1029-1033.
76. Wen Y, Zhou D, Liu T, Spincemaille P, Wang Y. An iterative spherical mean value method for background field removal in MRI. Magn Reson Med 2014;72:1065-1071.
77. Sun H, Wilman AH. Background field removal using spherical mean value filtering and Tikhonov regularization. Magn Reson Med 2014;71:1151-1157.
78. Zhou P-b. Numerical analysis of electromagnetic fields. Berlin, Germany; New York: Springer-Verlag; 1993. pp. xxi, 406.
79. Marques JP, Bowtell R. Application of a Fourier-based method for rapid calculation of field inhomogeneity due to spatial variation of magnetic susceptibility Concept Magn Reson 2005;25B:65-78.
80. Golub G, Loan CV. Matrix computations. Baltimore, MD: Johns Hopkins University Press; 1996.
81. Pruessmann KP, Weiger M, Peter B, Peter B. Advances in sensitivity encoding with arbitrary k-space trajectories. Magn Reson Med 2001;46:638-651.
82. Hansen PC. The truncated SVD as a method for regularization. BIT Numer Math 1987;27:534-553.
83. Liu T, Xu W, Spincemaille P, Avestimehr AS, Wang Y. Accuracy of the morphology enabled dipole inversion (MEDI) algorithm for quantitative susceptibility mapping in MRI. IEEE Trans Med Imaging 2012;31:816-824.
84. Tarantola A. Inverse problem theory and methods for model parameter estimation. Philadelphia, PA: SIAM; 2005.
85. Bauer F, Lukas MA. Comparingparameter choice methods for regularization of ill-posed problems. Mathematics and Computers in Simulation 2011;81:1795-1841.
86. Morozov VA, Nashed MZ. Methods for solving incorrectly posed problems. New York: Springer-Verlag; 1984. pp. xviii, 257.
87. Engl HW, Hanke M, Neubauer A. Regularization of inverse problems. Dordrecht, The Netherlands: Kluwer; 2000.
88. Wang S, Liu T, Chen W, Spincemaille P, Wisnieff C, Tsiouris AJ, Zhu W, Pan C, Zhao L, Wang Y. Noise effects in various quantitative susceptibility mapping methods. IEEE Trans Biomed Eng 2013;60:3441-3448.
89. Schweser F, Deistung A, Lehr BW, Reichenbach JR. Differentiation between diamagnetic and paramagnetic cerebral lesions based on magnetic susceptibility mapping. Med Phys 2010;37:5165-5178.
90. Bilgic B, Pfefferbaum A, Rohlfing T, Sullivan EV, Adalsteinsson E. MRI estimates of brain iron concentration in normal aging using quantitative susceptibility mapping. Neuroimage 2012;59:2625-2635.
91. Shewchuk JR. An introduction to the conjugate gradient method without the agonizing pain. 1994. Pittsburgh, PA: School of Computer Science, Carnegie Mellon University. Available at: http://www.cs.cmu.edu/~quake-papers/painless-conjugate-gradient.pdf. Accessed December 1, 2013.
92. Liu T, Liu J, de Rochefort L, Spincemaille P, Khalidov I, Ledoux JR, Wang Y. Morphology enabled dipole inversion (MEDI) from a singleangle acquisition: comparison with COSMOS in human brain imaging. Magn Reson Med 2011;66:777-783.
93. Elad M. Sparse and redundant representations: from theory to applications in signal and image processing. New York: Springer; 2010. p. 396.
94. Wharton S, Bowtell R. Whole-brain susceptibility mapping at high field: a comparison of multiple- and single-orientation methods. Neuroimage 2010;53:515-525.
95. Li J, Chang S, Liu T, Wang Q, Cui D, Chen X, Jin M, Wang B, Pei M, Wisnieff C, Spincemaille P, Zhang M, Wang Y. Reducing the object orientation dependence of susceptibility effects in gradient echo MRI through quantitative susceptibility mapping. Magn Reson Med 2012;68:1563-1569.
96. Xie L, Sparks MA, Li W, Qi Y, Liu C, Coffman TM, Johnson GA. Quantitative susceptibility mapping of kidney inflammation and fibrosis in type 1 angiotensin receptor-deficient mice. NMR Biomed 2013;26:1853-1863.
97. Chen W, Zhu W, Kovanlikaya I, Kovanlikaya A, Liu T, Wang S, Salustri C, Wang Y. Intracranial calcifications and hemorrhages: characterization with quantitative susceptibility mapping. Radiology 2014;270:496-505.
98. Sarmiento de la Iglesia MM, Lecumberri Cortes G, Lecumberri Cortes I, Oleaga Zufiria L, Isusi Fontan M, Grande Icaran D. [Intracranial calcifications on MRI]. Radiologia 2006;48:19-26.
99. Kozic D, Todorovic-Djilas L, Semnic R, Miucin-Vukadinovic I, Lucic M. MR imaging-An unreliable and potentially misleading diagnostic modality in patients with intracerebral calcium depositions. Case report. Neuro Endocrinol Lett 2009;30:553-557.
100. Wu Z, Mittal S, Kish K, Yu Y, Hu J, Haacke EM. Identification of calcification with MRI using susceptibility-weighted imaging: a case study. J Magn Reson Imaging 2009;29:177-182.
101. Yamada N, Imakita S, Sakuma T, Takamiya M. Intracranial calcification on gradient-echo phase image: depiction of diamagnetic susceptibility. Radiology 1996;198:171-178.
102. Prokop M, Galanski M. Spiral and multislice computed tomography of the body. Stuttgart, Germany; New York: Thieme; 2003. pp. xii, 1090.
103. Huisman TA. Intracranial hemorrhage: ultrasound, CT and MRI findings. Eur Radiol 2005;15:434-440.
104. Makariou E, Patsalides AD. Intracranial calcifications. Appl Radiol 2009;38:48-60.
105. Shental N, Bar-Hillel A, Hertz T, Weinshall D. Computing Gaussian mixture models with EM using side-information. Jerusalem, Israel: Hebrew University of Jerusalem; 2003.
106. Deistung A, Schweser F, Wiestler B, et al. Quantitative susceptibility mapping differentiates between blood depositions and calcifications in patients with glioblastoma. PloS One 2013;8:e57924.
107. Liu C, Li W, Johnson GA, Wu B. High-field (9.4 T) MRI of brain dysmyelination by quantitative mapping of magnetic susceptibility. Neuroimage 2011;56:930-938.
108. Bradley WG, Jr. MR appearance of hemorrhage in the brain. Radiology 1993;189:15-26.
109. Heier LA, Amster JL, Zimmerman RD, Deck MD. Focal recurrent hemorrhage on magnetic resonance at 0.5 Tesla. An aid to the diagnosis of cryptic cerebral vascular malformations. Acta Radiol Suppl 1986;369:113-115.
110. Zimmerman RD, Heier LA, Snow RB, Liu DP, Kelly AB, Deck MD. Acute intracranial hemorrhage: intensity changes on sequential MR scans at 0.5 T. AJR Am J Roentgenol 1988;150:651-661.
111. Liu T, Surapaneni K, Lou M, Cheng L, Spincemaille P, Wang Y. Cerebral microbleeds: burden assessment by using quantitative susceptibility mapping. Radiology 2012;262:269-278.
112. Kidwell CS, Chalela JA, Saver JL, et al. Comparison of MRI and CT for detection of acute intracerebral hemorrhage. JAMA 2004;292:1823-1830.
113. Fiebach JB, Schellinger PD, Gass A, et al. Stroke magnetic resonance imaging is accurate in hyperacute intracerebral hemorrhage: a multicenter study on the validity of stroke imaging. Stroke 2004;35:502-506.
114. Broderick JP, Brott TG, Duldner JE, Tomsick T, Huster G. Volume of intracerebral hemorrhage. A powerful and easy-to-use predictor of 30-day mortality. Stroke 1993;24:987-993.
115. Davis SM, Broderick J, Hennerici M, Brun NC, Diringer MN, Mayer SA, Begtrup K, Steiner T. Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage. Neurology 2006;66:1175-1181.
116. Klohs J, Deistung A, Schweser F, Grandjean J, Dominietto M, Waschkies C, Nitsch RM, Knuesel I, Reichenbach JR, Rudin M. Detection of cerebral microbleeds with quantitative susceptibility mapping in the ArcAbeta mouse model of cerebral amyloidosis. J Cereb Blood Flow Metab 2011;31:2282-2292.
117. Wang S, Lou M, Liu T, Cui D, Chen X, Wang Y. Hematoma volume measurement in gradient echo MRI using quantitative susceptibility mapping. Stroke 2013;44:2315-2317.
118. Haacke EM, Tang J, Neelavalli J, Cheng YC. Susceptibility mapping as a means to visualize veins and quantify oxygen saturation. J Magn Reson Imaging 2010;32:663-676.
119. Fan AP, Bilgic B, Gagnon L, Witzel T, Bhat H, Rosen BR, Adalsteinsson E. Quantitative oxygenation venography from MRI phase. Magn Reson Med 2014;72:149-159.
120. Jain V, Abdulmalik O, Propert KJ, Wehrli FW. Investigating the magnetic susceptibility properties of fresh human blood for noninvasive oxygen saturation quantification. Magn Reson Med 2012;68:863-867.
121. Powers WJ, Grubb RL, Jr., Darriet D, Raichle ME. Cerebral blood flow and cerebral metabolic rate of oxygen requirements for cerebral function and viability in humans. J Cereb Blood Flow Metab 1985;5:600-608.
122. Detre JA, Zhang W, Roberts DA, Silva AC, Williams DS, Grandis DJ, Koretsky AP, Leigh JS. Tissue specific perfusion imaging using arterial spin labeling. NMR Biomed 1994;7:75-82.
123. An H, Lin W. Quantitative measurements of cerebral blood oxygen saturation using magnetic resonance imaging. J Cereb Blood Flow Metab 2000;20:1225-1236.
124. Bulte DP, Kelly M, Germuska M, Xie J, Chappell MA, Okell TW, Bright MG, Jezzard P. Quantitative measurement of cerebral physiology using respiratory-calibrated MRI. Neuroimage 2012;60:582-591.
125. Gauthier CJ, Hoge RD. Magnetic resonance imaging of resting OEF and CMRO (2) using a generalized calibration model for hypercapnia and hyperoxia. Neuroimage 2012;60:1212-1225.
126. Wise RG, Harris AD, Stone AJ, Murphy K. Measurement of OEF and absolute CMRO2: MRI-based methods using interleaved and combined hypercapnia and hyperoxia. Neuroimage 2013;83:135-147.
127. Zhang J, Pei M, Liu T, Gupta A, Wisnieff C, Sanelli PC, Spincemaille P, Wang Y. Quantitative susceptibility mapping (QSM) for high resolution quantitative cerebral metabolic rate of oxygen. In Proceedings of the 21st Annual Meeting of ISMRM, Salt Lake City, Utah, USA, 2013. p. 3334.
128. Moos T, Morgan EH. The metabolism of neuronal iron and its pathogenic role in neurological disease: review. Ann NY Acad Sci 2004;1012:14-26.
129. Lee DW, Andersen JK, Kaur D. Iron dysregulation and neurodegeneration: the molecular connection. Mol Interv 2006;6:89-97.
130. Zecca L, Youdim MB, Riederer P, Connor JR, Crichton RR. Iron, brain ageing and neurodegenerative disorders. Nat Rev Neurosci 2004;5:863-873.
131. Crichton RR. Iron metabolism: from molecular mechanisms to clinical consequences. Chichester, UK: John Wiley & Sons; 2009. pp. xx, 461.
132. Lim IA, Faria AV, Li X, Hsu JT, Airan RD, Mori S, van Zijl PC. Human brain atlas for automated region of interest selection in quantitative susceptibility mapping: Application to determine iron content in deep gray matter structures. Neuroimage 2013;82:449-469.
133. Zheng W, Nichol H, Liu S, Cheng YC, Haacke EM. Measuring iron in the brain using quantitative susceptibility mapping and x-ray fluorescence imaging. Neuroimage 2013;78:68-74.
134. Oshiro S, Morioka MS, Kikuchi M. Dysregulation of iron metabolism in Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis. Adv Pharmacol Sci 2011;2011:378278.
135. Crichton RR, Dexter DT, Ward RJ. Brain iron metabolism and its perturbation in neurological diseases. J Neural Transm 2011;118:301-314.
136. Nunez MT, Urrutia P, Mena N, Aguirre P, Tapia V, Salazar J. Iron toxicity in neurodegeneration. Biometals 2012;25:761-776.
137. Williams R, Buchheit CL, Berman NE, LeVine SM. Pathogenic implications of iron accumulation in multiple sclerosis. J Neurochem 2012;120:7-25.
138. Dexter DT, Wells FR, Agid F, Agid Y, Lees AJ, Jenner P, Marsden CD. Increased nigral iron content in postmortem parkinsonian brain. Lancet 1987;2:1219-1220.
139. Riederer P, Sofic E, Rausch WD, Schmidt B, Reynolds GP, Jellinger K, Youdim MB. Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains. J Neurochem 1989;52:515-520.
140. Hirsch EC, Brandel JP, Galle P, Javoy-Agid F, Agid Y. Iron and aluminum increase in the substantia nigra of patients with Parkinson's disease: an x-ray microanalysis. J Neurochem 1991;56:446-451.
141. Oakley AE, Collingwood JF, Dobson J, Love G, Perrott HR, Edwardson JA, Elstner M, Morris CM. Individual dopaminergic neurons show raised iron levels in Parkinson disease. Neurology 2007;68:1820-1825.
142. Lotfipour AK, Wharton S, Schwarz ST, Gontu V, Schafer A, Peters AM, Bowtell RW, Auer DP, Gowland PA, Bajaj NP. High resolution magnetic susceptibility mapping of the substantia nigra in Parkinson's disease. J Magn Reson Imaging 2012;35:48-55.
143. ∗ a new MRI biomarker for the progression of Parkinson's disease? A longitudinal follow-up. PloS One 2013;8:e57904.
144. Youdim MB, Ben-Shachar D, Riederer P. Iron in brain function and dysfunction with emphasis on Parkinson's disease. Eur Neurol 1991;31(suppl 1):34-40.
145. Jomova K, Vondrakova D, Lawson M, Valko M. Metals, oxidative stress and neurodegenerative disorders. Mol Cell Biochem 2010;345:91-104.
146. Hashimoto M, Takeda A, Hsu LJ, Takenouchi T, Masliah E. Role of cytochrome c as a stimulator of alpha-synuclein aggregation in Lewy body disease. J Biol Chem 1999;274:28849-28852.
147. Li W, Jiang H, Song N, Xie J. Oxidative stress partially contributes to iron-induced alpha-synuclein aggregation in SK-N-SH cells. Neurotox Res 2011;19:435-442.
148. ∗-weighted MRI at 3 Tesla. Magn Reson Med 1994;32:335-341.
149. Gorell JM, Ordidge RJ, Brown GG, Deniau JC, Buderer NM, Helpern JA. Increased iron-related MRI contrast in the substantia nigra in Parkinson's disease. Neurology 1995;45:1138-1143.
150. Bartzokis G, Cummings JL, Markham CH, Marmarelis PZ, Treciokas LJ, Tishler TA, Marder SR, Mintz J. MRI evaluation of brain iron in earlier- and later-onset Parkinson's disease and normal subjects. Magn Reson Imaging 1999;17:213-222.
151. Brass SD, Chen NK, Mulkern RV, Bakshi R. Magnetic resonance imaging of iron deposition in neurological disorders. Top Magn Reson Imaging 2006;17:31-40.
152. Wallis LI, Paley MN, Graham JM, Grunewald RA, Wignall EL, Joy HM, Griffiths PD. MRI assessment of basal ganglia iron deposition in Parkinson's disease. J Magn Reson Imaging 2008;28:1061-1067.
153. ∗ maps, T (2)-weighted-, and FLAIR-SPACE. Invest Radiol 2010;45:795-802.
154. Haacke EM, Ayaz M, Khan A, Manova ES, Krishnamurthy B, Gollapalli L, Ciulla C, Kim I, Petersen F, Kirsch W. Establishing a baseline phase behavior in magnetic resonance imaging to determine normal vs. abnormal iron content in the brain. J Magn Reson Imaging 2007;26:256-264.
155. Zhang W, Sun SG, Jiang YH, Qiao X, Sun X, Wu Y. Determination of brain iron content in patients with Parkinson's disease using magnetic susceptibility imaging. Neurosci Bull 2009;25:353-360.
156. Huang XM, Sun B, Xue YJ, Duan Q. [Susceptibility-weighted imaging in detecting brain iron accumulation of Parkinson's disease]. Zhonghua Yi Xue Za Zhi 2010;90:3054-3058.
157. Zhang J, Zhang Y, Wang J, Cai P, Luo C, Qian Z, Dai Y, Feng H. Characterizing iron deposition in Parkinson's disease using susceptibility-weighted imaging: an in vivo MR study. Brain Res 2010;1330:124-130.
158. Jin L, Wang J, Zhao L, Jin H, Fei G, Zhang Y, Zeng M, Zhong C. Decreased serum ceruloplasmin levels characteristically aggravate nigral iron deposition in Parkinson's disease. Brain 2011;134:50-58.
159. Jin L, Wang J, Jin H, Fei G, Zhang Y, Chen W, Zhao L, Zhao N, Sun X, Zeng M, Zhong C. Nigral iron deposition occurs across motor phenotypes of Parkinson's disease. Eur J Neurol 2012;19:969-976.
160. Schafer A, Forstmann BU, Neumann J, Wharton S, Mietke A, Bowtell R, Turner R. Direct visualization of the subthalamic nucleus and its iron distribution using high-resolution susceptibility mapping. Hum Brain Mapp 2012;33:2831-2842.
161. Liu T, Eskreis-Winkler S, Schweitzer AD, Chen W, Kaplitt MG, Tsiouris AJ, Wang Y. Improved subthalamic nucleus depiction with quantitative susceptibility mapping. Radiology 2013;269:216-223.
162. Langkammer C, Schweser F, Krebs N, et al. Quantitative susceptibility mapping (QSM) as a means to measure brain iron? A post mortem validation study. NeuroImage 2012;62:1593-1599.
163. Acosta-Cabronero J, Williams GB, Cardenas-Blanco A, Arnold RJ, Lupson V, Nestor PJ. In vivo quantitative susceptibility mapping (QSM) in Alzheimer's disease. PloS One 2013;8:e81093.
164. Okun MS. Deep-brain stimulation for Parkinson's disease. N Engl J Med 2012;367:10.
165. Fox SH, Katzenschlager R, Lim SY, Ravina B, Seppi K, Coelho M, Poewe W, Rascol O, Goetz CG, Sampaio C. The Movement Disorder Society Evidence-Based Medicine Review Update: treatments for the motor symptoms of Parkinson's disease. Mov Disord 2011;26(suppl 3):S2-S41.
166. Bronstein JM, Tagliati M, Alterman RL, et al. Deep brain stimulation for Parkinson disease: an expert consensus and review of key issues. Arch Neurol 2011;68:165.
167. Deuschl G, Schade-Brittinger C, Krack P, et al A randomized trial of deep-brain stimulation for Parkinson's disease. N Engl J Med 2006;355:896-908.
168. Burchiel KJ, McCartney S, Lee A, Raslan AM. Accuracy of deep brain stimulation electrode placement using intraoperative computed tomography without microelectrode recording. J Neurosurg 2013;119:301-306.
169. Holl EM, Petersen EA, Foltynie T, Martinez-Torres I, Limousin P, Hariz MI, Zrinzo L. Improving targeting in image-guided frame-based deep brain stimulation. Neurosurgery 2010;67(suppl operative 2):437-447.
170. Kelman C, Ramakrishnan V, Davies A, Holloway K. Analysis of stereotactic accuracy of the Cosman-Robert-Wells frame and nexframe frameless systems in deep brain stimulation surgery. Stereotact Funct Neurosurg 2010;88:288-295.
171. Balachandran R, Welch EB, Dawant BM, Fitzpatrick JM. Effect of MR distortion on targeting for deep-brain stimulation. IEEE Trans Biomed Eng 2010;57:1729-1735.
172. D'Haese PF, Pallavaram S, Konrad PE, Neimat J, Fitzpatrick JM, Dawant BM. Clinical accuracy of a customized stereotactic platform for deep brain stimulation after accounting for brain shift. Stereotact Funct Neurosurg 2010;88:81-87.
173. Zrinzo L, van Hulzen AL, Gorgulho AA, Limousin P, Staal MJ, De Salles AA, Hariz MI. Avoiding the ventricle: a simple step to improve accuracy of anatomical targeting during deep brain stimulation. J Neurosurg 2009;110:1283-1290.
174. Hamid NA, Mitchell RD, Mocroft P, Westby GW, Milner J, Pall H. Targeting the subthalamic nucleus for deep brain stimulation: technical approach and fusion of pre- and postoperative MR images to define accuracy of lead placement. J Neurol Neurosurg Psychiatry 2005;76:409-414.
175. Simon SL, Douglas P, Baltuch GH, Jaggi JL. Error analysis of MRI and leksell stereotactic frame target localization in deep brain stimulation surgery. Stereotact Funct Neurosurg 2005;83:1-5.
176. Ferroli P, Franzini A, Marras C, Maccagnano E, D'Incerti L, Broggi G. A simple method to assess accuracy of deep brain stimulation electrode placement: pre-operative stereotactic CT++ostoperative MR image fusion. Stereotact Funct Neurosurg 2004;82:14-19.
177. Shahlaie K, Larson PS, Starr PA. Intraoperative computed tomography for deep brain stimulation surgery: technique and accuracy assessment. Neurosurgery 2011;68(suppl operative 1):114-124; discussion 124.
178. Caire F, Gantois C, Torny F, Ranoux D, Maubon A, Moreau JJ. Intraoperative use of the Medtronic O-Arm for deep brain stimulation procedures. Stereotact Funct Neurosurg 2010;88:109-114.
179. Fiegele T, Feuchtner G, Sohm F, Bauer R, Anton JV, Gotwald T, Twerdy K, Eisner W. Accuracy of stereotactic electrode placement in deep brain stimulation by intraoperative computed tomography. Parkinsonism Relat Disord 2008;14:595-599.
180. Videen TO, Campbell MC, Tabbal SD, Karimi M, Hershey T, Perlmutter JS. Validation of a fiducial-based atlas localization method for deep brain stimulation contacts in the area of the subthalamic nucleus. J Neurosci Methods 2008;168:275-281.
181. Guridi J, Rodriguez-Oroz MC, Lozano AM, Moro E, Albanese A, Nuttin B, Gybels J, Ramos E, Obeso JA. Targeting the basal ganglia for deep brain stimulation in Parkinson's disease. Neurology 2000;55(suppl 6):S21-S28.
182. Kerl HU, Gerigk L, Pechlivanis I, Al-Zghloul M, Groden C, Nolte I. The subthalamic nucleus at 3.0 Tesla: choice of optimal sequence and orientation for deep brain stimulation using a standard installation protocol: clinical article. J Neurosurg 2012;117:1155-1165.
183. Abosch A, Yacoub E, Ugurbil K, Harel N. An assessment of current brain targets for deep brain stimulation surgery with susceptibilityweighted imaging at 7 tesla. Neurosurgery 2010;67:1745-1756; discussion 1756.
184. Cho ZH, Min HK, Oh SH, Han JY, Park CW, Chi JG, Kim YB, Paek SH, Lozano AM, Lee KH. Direct visualization of deep brain stimulation targets in Parkinson disease with the use of 7-Tesla magnetic resonance imaging. J Neurosurg 2010;113:639-647.
185. Shah RS, Chang SY, Min HK, Cho ZH, Blaha CD, Lee KH. Deep brain stimulation: technology at the cutting edge. J Clin Neurol 2010;6:167-182.
186. O'Gorman RL, Shmueli K, Ashkan K, Samuel M, Lythgoe DJ, Shahidiani A, Wastling SJ, Footman M, Selway RP, Jarosz J. Optimal MRI methods for direct stereotactic targeting of the subthalamic nucleus and globus pallidus. Eur Radiol 2011;21:130-136.
187. ∗-imaging at ultra-high magnetic field strength. Neuroimage 2013;65:299-314.
188. Liu T, Spincemaille P, de Rochefort L, Wong R, Prince M, Wang Y. Unambiguous identification of superparamagnetic iron oxide particles through quantitative susceptibility mapping of the nonlinear response to magnetic fields. Magn Reson Imaging 2010;28:1383-1389.
189. Wong R, Chen X, Wang Y, Hu X, Jin MM. Visualizing and quantifying acute inflammation using ICAM-1 specific nanoparticles and MRI quantitative susceptibility mapping. Ann Biomed Eng 2012;40:1328-1338.
190. Wang Y, Johnston DL, Breen JF, Huston J, 3rd, Jack CR, Julsrud PR, Kiely MJ, King BF, Riederer SL, Ehman RL. Dynamic MR digital subtraction angiography using contrast enhancement, fast data acquisition, and complex subtraction. Magn Reson Med 1996;36:551-556.
191. Donahue KM, Weisskoff RM, Burstein D. Water diffusion and exchange as they influence contrast enhancement. J Magn Reson Imaging 1997;7:102-110.
192. Roberts TP. Physiologic measurements by contrast-enhanced MR imaging: expectations and limitations. J Magn Reson Imaging 1997;7:82-90.
193. Schabel MC, Parker DL. Uncertainty and bias in contrast concentration measurements using spoiled gradient echo pulse sequences. Phys Med Biol 2008;53:2345-2373.
194. Stanisz GJ, Henkelman RM. Gd-DTPA relaxivity depends on macromolecular content. Magn Reson Med 2000;44:665-667.
195. Bowen CV, Zhang X, Saab G, Gareau PJ, Rutt BK. Application of the static dephasing regime theory to superparamagnetic iron-oxide loaded cells. Magn Reson Med 2002;48:52-61.
196. Terreno E, Geninatti Crich S, Belfiore S, Biancone L, Cabella C, Esposito G, Manazza AD, Aime S. Effect of the intracellular localization of a Gd-based imaging probe on the relaxation enhancement of water protons. Magn Reson Med 2006;55:491-497.
197. Zurkiya O, Chan AW, Hu X. MagA is sufficient for producing magnetic nanoparticles in mammalian cells, making it an MRI reporter. Magn Reson Med 2008;59:1225-1231.
198. Lauffer RB. Magnetic resonance contrast media: principles and progress. Magn Reson Q 1990;6:65-84.
199. Kirsch JE. Basic principles of magnetic resonance contrast agents. Top Magn Reson Imaging 1991;3:1-18.
200. Toth E, Helm L, Merbach A. Relaxivity of MRI contrast agents. Contrast agents I. Topics in current chemistry, volume 221. Berlin, Germany: Springer; 2002. p 61-101.
201. Xu B, Spincemaille P, Chen G, Agrawal M, Nguyen TD, Prince MR, Wang Y. Fast 3D contrast enhanced MRI of the liver using temporal resolution acceleration with constrained evolution reconstruction. Magn Reson Med 2013;69:370-381.
202. ∗ and QSM data. In Proceedings of the 21st Annual Meeting of ISMRM, Salt Lake City, Utah, USA, 2013. p 0585.
203. Hammond KE, Metcalf M, Carvajal L, Okuda DT, Srinivasan R, Vigneron D, Nelson SJ, Pelletier D. Quantitative in vivo magnetic resonance imaging of multiple sclerosis at 7 Tesla with sensitivity to iron. Ann Neurol 2008;64:707-713.
204. Haacke EM, Makki M, Ge Y, et al. Characterizing iron deposition in multiple sclerosis lesions using susceptibility weighted imaging. J Magn Reson Imaging 2009;29:537-544.
205. Hagemeier J, Heininen-Brown M, Poloni GU, et al. Iron deposition in multiple sclerosis lesions measured by susceptibility-weighted imaging filtered phase: a case control study. J Magn Reson Imaging 2012;36:73-83.
206. Eissa A, Lebel RM, Korzan JR, Zavodni AE, Warren KG, Catz I, Emery DJ, Wilman AH. Detecting lesions in multiple sclerosis at 4.7 tesla using phase susceptibility-weighting and T2-weighting. J Magn Reson Imaging 2009;30:737-742.
207. Walsh AJ, Lebel RM, Eissa A, et al. Multiple sclerosis: validation of MR imaging for quantification and detection of iron. Radiology 2013;267:531-542.
208. Khalil M, Langkammer C, Ropele S, et al. Determinants of brain iron in multiple sclerosis: a quantitative 3T MRI study. Neurology 2011;77:1691-1697.
209. Habib CA, Liu M, Bawany N, Garbern J, Krumbein I, Mentzel HJ, Reichenbach J, Magnano C, Zivadinov R, Haacke EM. Assessing abnormal iron content in the deep gray matter of patients with multiple sclerosis versus healthy controls. AJNR Am J Neuroradiol 2012;33:252-258.
210. Yao B, Bagnato F, Matsuura E, Merkle H, van Gelderen P, Cantor FK, Duyn JH. Chronic multiple sclerosis lesions: characterization with high-field-strength MR imaging. Radiology 2012;262:206-215.
211. Bagnato F, Hametner S, Yao B, van Gelderen P, Merkle H, Cantor FK, Lassmann H, Duyn JH. Tracking iron in multiple sclerosis: a combined imaging and histopathological study at 7 Tesla. Brain 2011;134:3602-3615.
212. Langkammer C, Liu T, Khalil M, Enzinger C, Jehna M, Fuchs S, Fazekas F, Wang Y, Ropele S. Quantitative susceptibility mapping in multiple sclerosis. Radiology 2013;267:551-559.
213. Al-Radaideh AM, Wharton SJ, Lim SY, Tench CR, Morgan PS, Bowtell RW, Constantinescu CS, Gowland PA. Increased iron accumulation occurs in the earliest stages of demyelinating disease: an ultra-high field susceptibility mapping study in clinically isolated syndrome. Mult Scler 2013;19:896-903.
214. Chen W, Gauthier SA, Gupta A, Comunale J, Liu T, Wang S, Pei M, Pitt D, Wang Y. Quantitative susceptibility mapping of multiple sclerosis lesions at various ages. Radiology 2014;271:183-192.
215. Yablonskiy DA, Luo J, Sukstanskii AL, Iyer A, Cross AH. Biophysical mechanisms of MRI signal frequency contrast in multiple sclerosis. Proc Natl Acad Sci U S A 2012;109:14212-14217.
216. Wiggermann V, Hernandez Torres E, Vavasour IM, Moore GR, Laule C, Mackay AL, Li DK, Traboulsee A, Rauscher A. Magnetic resonance frequency shifts during acute MS lesion formation. Neurology 2013;81:211-218.
217. Dixon WT. Simple proton spectroscopic imaging. Radiology 1984;153:189-194.
218. Reeder SB, Wen Z, Yu H, Pineda AR, Gold GE, Markl M, Pelc NJ. Multicoil Dixon chemical species separation with an iterative leastsquares estimation method. Magn Reson Med 2004;51:35-45.
219. Yu H, Reeder SB, Shimakawa A, Brittain JH, Pelc NJ. Field map estimation with a region growing scheme for iterative 3-point waterfat decomposition. Magn Reson Med 2005;54:1032-1039.
220. Hernando D, Haldar JP, Sutton BP, Ma J, Kellman P, Liang ZP. Joint estimation of water/fat images and field inhomogeneity map. Magn Reson Med 2008;59:571-580.
221. Hernando D, Kellman P, Haldar JP, Liang ZP. Robust water/fat separation in the presence of large field inhomogeneities using a graph cut algorithm. Magn Reson Med 2010;63:79-90.
222. Yablonskiy DA, Sukstanskii AL, Luo J, Wang X. Voxel spread function method for correction of magnetic field inhomogeneity effects in quantitative gradient-echo-based MRI. Magn Reson Med 2013;70:1283-1292.
223. Duyn JH, van Gelderen P, Li TQ, de Zwart JA, Koretsky AP, Fukunaga M. High-field MRI of brain cortical substructure based on signal phase. Proc Natl Acad Sci U S A 2007;104:11796-11801.
224. Zhong K, Leupold J, von Elverfeldt D, Speck O. The molecular basis for gray and white matter contrast in phase imaging. Neuroimage 2008;40:1561-1566.
225. He X, Yablonskiy DA. Biophysical mechanisms of phase contrast in gradient echo MRI. Proc Natl Acad Sci U S A 2009;106:13558-13563.
226. van Gelderen P, de Zwart JA, Lee J, Sati P, Reich DS, Duyn JH. Nonexponential T (2) decay in white matter. Magn Reson Med 2012;67:110-117.
227. Wharton S, Bowtell R. Fiber orientation-dependent white matter contrast in gradient echo MRI. Proc Natl Acad Sci U S A 2012;109:18559-18564.
228. ∗ relaxation in the brain. Neuroimage 2013;77:268-278.
229. Dibb R, Li W, Cofer G, Liu C. Microstructural origins of gadoliniumenhanced susceptibility contrast and anisotropy. Magn Reson Med 2014;72:1702-1711.
230. Liu C, Li W. Imaging neural architecture of the brain based on its multipole magnetic response. Neuroimage 2013;67:193-202.
231. Chen WC, Foxley S, Miller KL. Detecting microstructural properties of white matter based on compartmentalization of magnetic susceptibility. Neuroimage 2013;70:1-9.
232. Bakker CJ, Seppenwoolde JH, Vincken KL. Dephased MRI. Magn Reson Med 2006;55:92-97.
233. Sukstanskii AL, Yablonskiy DA. On the role of neuronal magnetic susceptibility and structure symmetry on gradient echo MR signal formation. Magn Reson Med 2014;71:345-353.
234. Liu C. Susceptibility tensor imaging. Magn Reson Med 2010;63:1471-1477.
235. Wisnieff C, Liu T, Spincemaille P, Wang S, Zhou D, Wang Y. Magnetic susceptibility anisotropy: cylindrical symmetry from macroscopically ordered anisotropic molecules and accuracy of MRI measurements using few orientations. Neuroimage 2013;70:363-376.
236. Li X, Vikram DS, Lim IA, Jones CK, Farrell JA, van Zijl PC. Mapping magnetic susceptibility anisotropies of white matter in vivo in the human brain at 7 T. Neuroimage 2012;62:314-330.
237. Liu C, Li W, Wu B, Jiang Y, Johnson GA. 3D fiber tractography with susceptibility tensor imaging. Neuroimage 2012;59:1290-1298.
238. Lee J, Shmueli K, Fukunaga M, van Gelderen P, Merkle H, Silva AC, Duyn JH. Sensitivity of MRI resonance frequency to the orientation of brain tissue microstructure. Proc Natl Acad Sci U S A 2010;107:5130-5135.